Fitzgerald Thomas A
Insider CIK 1854168 · RNAZ Interim CEO, CFO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNAZ Transcode Therapeutics, In | A Award deriv | 2026-09-09 | 2026-09-11 | 185,000 | — | $0 | 185,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2026-09-09 | 2026-09-11 | 185,000 | — | $0 | 185,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2024-06-14 | 2024-06-18 | 650,000 | — | $0 | 650,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2023-09-28 | 2023-10-02 | 49,350 | $0.51 | $25.2K | 56,318 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2023-05-19 | 2023-05-19 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2022-12-12 | 2022-12-14 | 100,000 | — | $0 | 100,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | P Buy | 2022-06-16 | 2022-06-17 | 12,000 | $1.27 | $15.2K | 139,377 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2022-03-01 | 2022-03-02 | 52,000 | — | $0 | 52,000 | SEC↗ |
| RNAZ Transcode Therapeutics, In | A Award deriv | 2022-02-01 | 2022-02-03 | 33,000 | — | $0 | 33,000 | SEC↗ |